Organization
TAHO Pharmaceuticals
1 clinical trial
Clinical trial
A Phase I, Randomized, Single-Dose, Open-Label, Four-Way Crossover Study to Evaluate the Comparative Bioavailability of Apixaban for TAH3311 Oral Dissolving Film Versus ELIQUIS® Oral Tablet in Healthy Male and Female SubjectsStatus: Completed, Estimated PCD: 2022-12-28